Navigation Links
Telik Announces Second Quarter 2009 Financial Results
Date:8/6/2009

PALO ALTO, Calif., Aug. 6 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK) today reported a net loss of $5.7 million, or $0.11 per share, for the second quarter ended June 30, 2009, compared with a net loss of $13.6 million, or $0.26 per share, for the comparable period in 2008.

For the quarter ended June 30, 2009, total operating costs and expenses were $6.3 million, compared with $11.0 million in the 2008 second quarter. Operating expenses in the 2009 second quarter included stock-based compensation expense of approximately $0.5 million. Operating expenses were approximately 43% lower in the second quarter of 2009 compared with the same period in 2008, primarily due to lower headcount as a result of our restructuring in February 2009, reduced research, clinical trial and related expenses and lower stock compensation expense.

For the six months ended June 30, 2009, Telik reported a net loss of $13.4 million, or $0.25 per share, compared with a net loss of $23.4 million, or $0.44 per share, for the six months ended June 30, 2008. Total operating expenses for the first six months of 2009 were $14.0 million, compared with $21.6 million for the first six months of 2008. Operating expenses in the first six months of 2009 included approximately $1.3 million in stock-based compensation expense. The reduction in operating expenses of approximately 35% in the first six months of 2009 compared with the same period in 2008 was primarily due to lower headcount, reduced research and clinical trial expenses and lower stock-based compensation expense.

At June 30, 2009, Telik had $50.6 million in cash, cash equivalents and investments including restricted investments, compared to $63.5 million at December 31, 2008.

About Telik

Telik, Inc. of Palo Al
'/>"/>

SOURCE Telik, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Telik Reports Preclinical Results at AACR Annual Meeting
2. Telik Implements Reorganization to Focus Resources Toward Drug Development Pipeline
3. Telik Announces New TRAP Drug Discovery Agreement
4. Telik Announces Financial Results for 2008 Third Quarter
5. Telik Announces Top-Line Results From Assist-5 Trial of Telcyta(R) in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and Resistant Ovarian Cancer
6. Telik Announces 2008 Third Quarter Financial Release, Conference Call and Webcast
7. Telik Announces Receipt of Nasdaq Notice
8. Teliks Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone
9. ReceptorBio Announces Diabetes License Agreement With Telik
10. Telik Announces Financial Results For 2008 Second Quarter
11. Telik Announces 2008 Second Quarter Financial Release, Conference Call and Webcast

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...tario, Nov. 24 Dow AgroS... assets of Hyland Seeds, a division of Thompsons L...d Seeds will further expand Dow AgroSciences, curr...introduction of SmartStax(TM) in 2010 and Do... in corn in 2012. The transactional close is expec...
(Date:11/24/2009)...RNewswire-FirstCall/ -- Sigma-Aldrich Corporation ...OMX conference on Tuesday, December 1st at 1:45 PM... may listen via live audio broadcast over the Inte... a ldrich.com/ . Users can click the "Webcast" ...drich: Sigma-Aldrich is a leading Life Science a...
(Date:11/24/2009)...IK, Iceland, November 24 ...nced the approval of all of its,"first day" motion... Delaware,(the "Bankruptcy Court"). deCODE last we...pter 11 of the United States Bankruptcy Code with ... by the Bankruptcy Court allow the company to cont...
(Date:11/24/2009)...ov. 24 NeurogesX, Inc. (...ed on developing and commercializing novel pain ma...iTonno, President and Chief Executive Officer, is ...ray Health Care Conference, to be held December 1-...New York. ,, Mr. DiTonno and Stephen Ghiglieri...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
...hnologies announced a new line of genotyping reag...Annual Clinical Virology Symposium in Florida. , ,...r disease in the United States and affects 4 milli...lly, according to a company statement. The new rea...llow labs to develop tests for the six different t...
...s Inc., a provider of services that help small bus...a web-based application that businesses can use to...sends e-mails to business owners reminding them of...s, as well as various meeting deadlines. , ,"Compl...es is often at the bottom of a long list of priori...
...n entrepreneur Ken Schlager started a company, he ...ces. This time around, Schlager is turning to the ...r help as he launches a cutting-edge technology th...eatment. , ,Schlager, a 75-year-old electrical eng...water and removes organic materials, while also di...
Other Biology Technology:CTT - Bridging the states entrepreneurial gap 2CTT - Bridging the states entrepreneurial gap 3
(Date:11/24/2009)... Antarctica has long held secrets of the earth,s ...ly, there has been very little information on the ...f ice for millions of years. Now, a team of resear...been funded to the tune of $10 million dollars by ... the bottom of things literally. These scientists...
(Date:11/23/2009)... research presents strong evidence that the "syner...oor traffic-related pollution and indoor endotoxin...the other exposure alone. , Environmental heal... College of Medicine have shown that children expo...es and indoor endotoxin during early life are six ...
(Date:11/23/2009)... by the Wildlife Conservation Society says that we...the Republic of Congopart of the "mother lode" of ... becoming increasingly threatened by growing human... protection of the swamp forests adjacent to the s...recent surveys confirmed that high densities of th...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Oramed Pharmaceuticals Reports Positive Results From a Study of Oral Insulin Capsule on Type 1 Diabetic Patients 13118 1Oramed Pharmaceuticals Reports Positive Results From a Study of Oral Insulin Capsule on Type 1 Diabetic Patients 13118 2Swissmedic Grants Debiopharm Marketing Authorisation for Moapar 28R 29 a New Therapeutic Avenue for the Treatment of Sexual Deviations 4759 1Swissmedic Grants Debiopharm Marketing Authorisation for Moapar 28R 29 a New Therapeutic Avenue for the Treatment of Sexual Deviations 4759 2Swissmedic Grants Debiopharm Marketing Authorisation for Moapar 28R 29 a New Therapeutic Avenue for the Treatment of Sexual Deviations 4759 3Next Generation Hemostatic Dressing Available for Military Emergencies 52198 1Next Generation Hemostatic Dressing Available for Military Emergencies 52198 2Next Generation Hemostatic Dressing Available for Military Emergencies 52198 3
...e confident, comfortable and flexible with their e...of cardiovascular disease than people who are not....um that helps people understand their eating habit... therapy. , "We wanted to see if people were at h... they were not eating competent to begin with," sa...
...enture capitalist Vinod Khosla told last years Bio...iversity why he believes fuel blends containing 85... supply. , Khosla who last year told The New Yo...in private companies developing ethanol production...al and special interest groups back ethanol, there...
...nstitute of Technology and Emory University have r...ence Foundation to establish "The Origins Project,...public outreach focused on the chemistry that may ...cludes the participation of Spelman College in Atl..., The NSF is supporting The Origins Project as pa...
Other Biology News:Eating competence may lower risk of heart disease 2Iowa State University conference examines developing bioeconomy 2Georgia Tech/Emory Center to study origin of life 2
... System provides optimized reagents and protocols ... genes by insertion of group II introns. The metho...rons and utilizes a simple PCR step to re-target t...n into the host genome. Utility of the technology ...
Mouse Anti-Human PPIL2 Monoclonal Antibody, Unconjugated, Clone 2E11 from Abnova Corporation
Mouse Anti-Human QARS Monoclonal Antibody, Unconjugated, Clone 5F5 from Abnova Corporation
Mouse Anti-IFNA2 Monoclonal Antibody, Unconjugated, Clone 1F11 from Abnova Corporation
Biology Products: